Effects of Upper Extremity Low Volume HIIT in Heart Failure
The Effect of Upper Extremity Low-Volume High-Intensity Interval Training on Physical and Cognitive Functions in Heart Failure Patients
1 other identifier
interventional
30
1 country
2
Brief Summary
This study was planned to investigate the effects of upper extremity low-volume high-intensity interval training (LV-HIIT) on physical and cognitive function in patients with heart failure with preserved ejection fraction(HFpEF).The research was planned as a randomized controlled trial. Patients with clinically stable HFpEF at cardiology clinic will be included in the study. These cases will be randomly divided into two groups: intervention group and control grup. After 8 weeks intervention physical functions before and after treatment; functional exercise capacity, arm exercise capacities , peripheral muscle strength , fatigue cognitive functions; anxiety and depression and fear of movement will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 23, 2024
CompletedFirst Posted
Study publicly available on registry
December 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 3, 2025
November 1, 2024
2 years
December 23, 2024
January 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
maximal arm exercises capacity
maximal arm exercises capacity will measurement with arm ergometer test.
At baseline and after 8 week
Functional capacity
Functional capacity will be assessed with the six-minute walk test (6MWT).
At baseline and after 8 week
Upper extremity muscle strength
Upper extremity muscle strength will be evaluated with a digital dynamometer and hand grip strength will be evaluated with a jamar.
At baseline and after 8 week
reaction time
The auditory and visual reaction times of the individuals will be determined. The instrument used during the test can give three stimuli and consists of two parts, In measuring the reaction times, care will be taken to ensure that the measurement area is a noiseless and light-receiving environment. Individuals will be told the technique of the test and will be asked to make 1 attempt against sound and light stimulation. After the trial, 3 measurements will be taken and the results will be recorded in milliseconds
At baseline and after 8 week
cognitive function
Mini mental Questionaire will use. Min 24 point is the cut of for this test
At baseline and after 8 week
Postural sway
The postural oscillations of the patients will be evaluated with the body oscillation device, which measures the oscillation in two axes. In this test, the participant will be asked to stand in the upright position with a distance of 10 cm between the two feet and to maintain your upright position for 30 seconds. The participant will be measured twice with the eyes open and closed. With these measurements, the mediolateral and anteroposterior oscillation distances of the patients will be measured and recorded on the computer
At baseline and after 8 week
heart rate variablity
At baseline and after 8 week
Secondary Outcomes (3)
hand steadness
At baseline and after 8 week
Anxiety and depresion
At baseline and after 8 week
activities of daily living
At baseline and after 8 week
Study Arms (2)
Patients
EXPERIMENTALİntervention Group: LV-HIIT
Control group
OTHERControl group
Interventions
Low-volume, high-intensity interval training with an arm ergometer will be given two days a week for a total of eight weeks.
Eligibility Criteria
You may qualify if:
- Clinical condition stable for ≥4 weeks.
- New York Heart Association functional classification I-II to III
- Over 18 years old
You may not qualify if:
- History of CABG surgery
- Unstable angina pectoris
- Severe arrhythmia
- Acute pericarditis, endocarditis, myocarditis
- Severe left ventricular failure (EF \<40%)
- Acute pulmonary embolism
- History of syncope
- Dissecting aneurysm
- Thrombophlebitis
- Orthopedic disorders that may interfere with exercise
- Uncontrolled hypertension, severe pulmonary arterial hypertension
- Moderate-severe valve disease
- Decompensated Congestive Heart Failure
- Electrolyte abnormalities
- Hypertrophic Cardiomyopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Tarsus University, TARSUS, Mersin
Mersin, Mersin, Turkey (Türkiye)
Nurel Ertürk, TARSUS, Mersin
Yenişehir, Mersin, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist. Prof.
Study Record Dates
First Submitted
December 23, 2024
First Posted
December 31, 2024
Study Start
November 1, 2024
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 3, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
All IPD collected throughout the trial, only IPD used in the results publication